Author Archives: Alexander Szewczak

More thoughts on drug company R&D productivity ranking

[updated]  Some comments I received on the previous post made me realize there was a more fundamental flaw in drug company R&D productivity rankings that should be highlighted. Drug discovery is by and large a high failure rate multistep process … Continue reading

Posted in Fixing Big Pharma Research, Pharmaceutical Industry | Tagged | Leave a comment

Who’s The Best In Drug Research? 22 Companies Ranked Incorrectly

Matt Herper at Forbes has a post on new pharmaceutical research productivity data from Richard Evans, a former Roche executive and Wall Street analyst.  Evans calculates metrics such as (1) Economic Returns to R&D spending, (2) Patents / $1M R&D spend, (3) Average … Continue reading

Posted in Fixing Big Pharma Research, Pharmaceutical Industry | Tagged , , | Leave a comment

Software is still eating the world

Russ Roberts has a new EconTalk podcast interview with Marc Andreessen that is worth a listen: Marc Andreessen, venture capitalist and co-creator of the early web browser Mosaic, talks with EconTalk host Russ Roberts about how success in venture capital is more about … Continue reading

Posted in Data Analysis, Innovation | Tagged , , , | Leave a comment

Apple and Google poised to enter the 3D printing market?

Speculation has been building that Apple and Google might be gearing up to produce consumer 3D printers (along with other tech giants).  Indeed, analysts have been urging Apple to do so. Apple, of course, was primarily responsible for the desktop publishing phenomena, … Continue reading

Posted in 3-D Printing, Innovation | Tagged , , , , | Leave a comment

Most Selective Colleges by State

Each state is marked with the logo of the most selective college located within that state.

Posted in Data Analysis | Tagged , | 3 Comments

MakerBot launches a push-button consumer 3D-printer

MakerBot‘s newest 3-D printer, the Makerbot Replictor Mini, started shipping yesterday.   Employing fast and easy “One Touch” 3D printing, the Mini is a cost-effective solution for small scale prototyping or teaching kids about creating and printing in three dimensions.  Makerbot also sells … Continue reading

Posted in 3-D Printing, Innovation | Tagged , , , | 1 Comment

Pfizer raises its bid for AstraZeneca – one last time?

Over the weekend, Pfizer finally made an official offer for AstraZeneca,  by raising its bid to $119B (15% higher than the last, unofficial, offer), and increasing the cash portion of the deal from 33% to 45%.  AZ had a market cap of … Continue reading

Posted in Pharmaceutical Industry | Tagged , , , | Leave a comment

FDA Drives Medical Innovation Overseas As 23andme Looks Elsewhere To Help People

Last Fall, the FDA blocked the personal genetic profiling offered by 23andMe, stopping the sale of the company’s home genetic testing kits in the U.S.  At the time TechFreedom issued a plea: We haven’t all used 23andMe yet, but those of us … Continue reading

Posted in Innovation, Science | Tagged , , | Leave a comment

Happy Mother’s Day

Mother’s Day is also Lilac Sunday at the Arnold Arboretum of Harvard University.  The Arboretum has 172 different varieties of lilacs (close to 400 individual plants) that put on quite a show around the second Sunday in May.

Posted in Photography | Tagged , , | Leave a comment

Pfizer is a shark that can’t stop feeding

So says John LaMattina, a former head of research at Pfizer: The only way for a shark to survive is to keep going forward. To maintain its leadership, Pfizer will again need to make a major acquisition in the next … Continue reading

Posted in Pharmaceutical Industry | Tagged , , , , | Leave a comment